GNCC Capital, Inc. (GNCP) Stock Price & Analysis
Educational signal · not a buy or sell recommendation · How to read this
Market cap $8.71M is the value of all shares combined.
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 18, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnswerGNCC Capital, Inc. (GNCP) trades at $0.00005. GNCC Capital, Inc., through its subsidiary, focuses on producing and selling cannabis CBD pharmaceutical grade oils. Market cap: $8.71M, Sector: Materials.
Price as of · Last analyzed: Mar 18, 2026Analyst Coverage for GNCP: GNCP does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage.
No score published: we hold no usable price for this ticker, and a grade beside a missing price says nothing.
GNCC Capital, Inc. (GNCP) Materials & Commodity Exposure
GNCC Capital, Inc. operates in the basic materials sector, specifically focusing on the production and distribution of cannabis CBD pharmaceutical grade oils in Colombia and Latin America. The company faces significant competition and regulatory hurdles in the evolving cannabis market.
What Is the Investment Thesis for GNCP?
GNCC Capital, Inc. presents a speculative investment opportunity within the cannabis CBD pharmaceutical sector in Latin America. The company's focus on pharmaceutical-grade CBD oils positions it to potentially capture a segment of the market demanding high-quality products. However, the company's small market capitalization of $8.71M and negative beta of -38.68 indicate high volatility and sensitivity to market movements. Growth depends on successful navigation of regulatory hurdles, securing distribution partnerships, and scaling production efficiently. Investors should carefully consider the risks associated with investing in a micro-cap company operating in a rapidly evolving and highly regulated industry.
Based on FMP financials and quantitative analysis
GNCP Key Highlights
GNCC Capital, Inc. operates in the cannabis CBD pharmaceutical sector through its subsidiary BioCann Pharma S.A.S.
- The company focuses on producing and selling cannabis CBD pharmaceutical grade oils.
- GNCC Capital distributes its products through channels in Colombia and throughout Latin America.
- The company is based in Las Vegas, Nevada.
- GNCC Capital has a market capitalization of $8.71M.
Who Are GNCP's Competitors?
GNCP is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| BGL Blue Gold Limited | $0.19 | -3.55% | $8.24M | — |
| NAMM Namib Minerals | $1.26 | -3.08% | $68.7M | 62 5-pillar |
| PZG Paramount Gold Nevada Corp. | $1.20 | -1.64% | $103M | — |
| MINE Mayfair Gold Corp. | $2.65 | -2.93% | $178M | 44 5-pillar |
| GLDG GoldMining Inc. | $0.94 | -0.61% | $202M | 45 5-pillar |
| USAU U.S. Gold Corp. | $14.47 | -1.23% | $239M | 43 5-pillar |
| GORO Gold Resource Corporation | $3.26 | +2.19% | $246M | 46 5-pillar |
| VGZ Vista Gold Corp. | $2.67 | -0.37% | $390M | 48 5-pillar |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are GNCP's Key Strengths?
Focus on pharmaceutical-grade CBD oils.
- Distribution network in Colombia and Latin America.
- Potential for growth in the expanding cannabis market.
- Expertise in cannabis cultivation and processing.
What Are GNCP's Weaknesses?
Small market capitalization.
- Dependence on a single subsidiary.
- Limited product diversification.
- Negative beta indicating high volatility.
What Are the Key Risks for GNCP?
Regulatory setbacks in the cannabis industry.
- Intense competition from established pharmaceutical companies.
- Fluctuations in the price of cannabis and CBD.
- Dependence on a single subsidiary for revenue generation.
- Negative beta indicating high volatility.
What Are GNCP's Competitive Advantages?
- Focus on pharmaceutical-grade CBD oil production.
- Established distribution channels in Colombia and Latin America.
- Expertise in navigating the regulatory landscape of the cannabis industry.
- Potential for brand recognition and customer loyalty through consistent product quality.
What Does GNCP Do?
GNCC Capital, Inc., based in Las Vegas, Nevada, operates through its subsidiary, BioCann Pharma S.A.S., to produce and distribute cannabis CBD pharmaceutical grade oils. The company focuses on serving the Latin American market, primarily Colombia, through established distribution channels. GNCC Capital aims to capitalize on the growing demand for CBD products in the pharmaceutical sector within the region. The company's business model centers around cultivating, processing, and distributing high-quality CBD oils that meet pharmaceutical standards. GNCC Capital navigates the complex regulatory landscape of the cannabis industry in Latin America to ensure compliance and market access. The company's success hinges on its ability to maintain consistent product quality, secure distribution partnerships, and adapt to evolving regulations in the cannabis market.
What Products and Services Does GNCP Offer?
- Produces cannabis CBD pharmaceutical grade oils.
- Sells products through distribution channels.
- Operates primarily in Colombia and throughout Latin America.
- Focuses on the pharmaceutical sector.
- Cultivates and processes CBD oils.
- Navigates the regulatory landscape of the cannabis industry.
How Does GNCP Make Money?
- Cultivation and processing of cannabis plants to extract CBD oil.
- Manufacturing of pharmaceutical-grade CBD oil products.
- Distribution of products through established channels in Colombia and Latin America.
- Revenue generation through the sale of CBD oil products to distributors and end-users.
What Industry Does GNCP Operate In?
GNCC Capital, Inc. operates within the evolving cannabis industry, specifically targeting the CBD pharmaceutical sector in Latin America. The global cannabis market is experiencing rapid growth, driven by increasing legalization and acceptance of cannabis for medical and recreational purposes. However, the industry faces challenges such as regulatory uncertainty, intense competition, and varying consumer preferences. GNCC Capital's success depends on its ability to navigate these challenges and establish a strong presence in its target markets. The competitive landscape includes both established pharmaceutical companies and emerging cannabis producers.
Who Are GNCP's Key Customers?
- Pharmaceutical companies seeking high-quality CBD ingredients.
- Distributors of pharmaceutical products in Colombia and Latin America.
- Patients seeking CBD-based treatments for various medical conditions.
- Retailers of health and wellness products.
Research confidence
Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.
- ● Scoring coverage unknown
- ● No usable price
- ● No filing on record
- ● No analyst coverage
Company Profile
GNCC Capital, Inc. operates in the Gold industry within the Basic Materials sector. It is headquartered in Las Vegas, US. The company is led by CEO Nicolaas Edward Blom. GNCP has traded publicly since 2009.
GNCP Valuation & Market Position
With a $8.71M market cap, GNCC Capital, Inc. sits in the micro-cap segment of the market.
Key Financial Metrics
Return on equity for GNCC Capital, Inc. stands at 357.9%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -15.5%, showing how much profit it generates from its asset base. A current ratio of 9.98 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is -15.9%, the inverse of the P/E and a quick read on earnings relative to price.
GNCP Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
GNCP Latest News
No recent news available for GNCP.
GNCP Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for GNCP.
Price Targets
Wall Street price target analysis for GNCP.
GNCP MoonshotScore
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for GNCP; grades run from A+ (80-100) to F (below 30).
GNCP OTC Market Information
GNCP trades on the OTC Other market tier of OTC Markets.
- OTC Tier: OTC Other
Common Questions About GNCP (Materials)
What are the main risks for GNCP?
GNCC Capital, Inc. faces several risks inherent in the cannabis industry, including regulatory uncertainty, intense competition, and fluctuations in the price of cannabis and CBD.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
MoonshotScore is not published for this security.
Data provided for informational purposes only.
- Information is based on limited available data.